Gan & Lee Pharmaceuticals

IPO

Gan & Lee - Dedicated to Improving Human Health

Public · Beijing, China · Founded 1998

Headquarters
Beijing
Employees
1001–5000
Founded
1998
Business Model
B2B
Website
ganlee.com
Last Round
Series BJan 2011
Rounds
2
Type
Public

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Chinese biopharmaceutical company that developed the first domestic insulin analog and manufactures a series of recombinant insulin products.

Summary

Gan & Lee Pharmaceuticals is a Healthcare company based in Beijing, China, founded in 1998. Its most recent funding was a Series B round in Jan 2011. Investors include Qiming VP.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPO2018 (est.)
$227.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gan & Lee Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/gan-lee-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/gan-lee-pharmaceuticals" alt="Gan & Lee Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>